More importantly, the RUNX2 gene promoter has been shown to be under direct control of BRD4 during osteoblast differentiation (197) as well as in cancer (198), suggesting that BRD4 may serve as a “master-regulator” of both inflammation and vascular calcification in parallel. Here, BRD4 is linked to cancer.